Not independent
Tenure on this board
0.6 yrs
2 nominees · 2 ballot items.
Election of two Class I directors; Ratification of appointment of BDO USA, P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026.
Elect two Class I director nominees (Luis Peña and Eugene A. Bauer, M.D.) to hold office until the 2029 Annual Meeting.
Ratify the Audit Committee’s appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
The Audit Committee has appointed BDO USA, P.C. as the Company’s independent registered public accounting firm for fiscal year 2026 and seeks shareholder ratification as a matter of good corporate practice. The proposal asks shareholders to ratify a longstanding relationship (BDO has audited the Company since 2022) to provide continuity in audit oversight. Management is submitting the selection for ratification to maintain governance best practices and to provide stockholders an opportunity to express their views; the Board and Audit Committee recommend voting for the ratification because the committee has reviewed BDO’s qualifications, independence, and performance and determined continuation aligns with the Company’s interests. If shareholders do not ratify, the Audit Committee will reconsider the appointment; even if ratified, the Audit Committee retains authority to change auditors if warranted.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | EQT Fund Management S.a r.l. | 13.7% | 4,929,633 | $113M |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 9.7% | 3,494,638 | $80M |
| 3 | Pivotal bioVenture Partners Investment Advisor LLC | 5.3% | 1,926,943 | $44M |
| 4 | Andera Partners | 5.3% | 1,897,362 | $44M |
| 5 | RTW INVESTMENTS, LP | 4.2% | 1,502,235 | $35M |
| 6 | MPM BioImpact LLC | 4.0% | 1,455,863 | $33M |
| 7 | Nan Fung Group Holdings Ltd | 4.0% | 1,441,032 | $33M |
| 8 | SymBiosis Capital Partners, LLC | 3.6% | 1,280,778 | $29M |
| 9 | EVENTIDE ASSET MANAGEMENT, LLC | 3.4% | 1,209,129 | $28M |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.1% | 1,104,409 | $25M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.